The US Food and Drug Administration (FDA) is set to fully approve the Pfizer/BioNTech COVID-19 vaccine by early September, the New York Times reported.
The agency has said that it hopes full approval will instill trust in the vaccine and encourage Americans who are still on the fence to get their first doses.
Pfizer is also seeking emergency use authorization for booster doses of its vaccine.
However, on August 4 the World Health Organization called for a moratorium on booster shots through at least September, pointing out that poorer countries are still struggling to access the first doss of the vaccines.
The organization asked wealthier nations to instead donate shots to help vaccinate at least 10 percent of people in every country in the next two months.
More than 57 percent of the population has received at least one dose, and 49 percent of people are fully vaccinated in the United States. As of August 4, the U.S. had administered more than 347 million shots of the authorized vaccines and had distributed more than 401 million doses.
A global media for the latest news, entertainment, music fashion, and more.
